Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Apellis Pharmaceuticals
Apellis Pharmaceuticals
(APLS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Empaveli
Pegcetacoplan
2021-05-14
2026-2038
Paroxysmal hemoglobinuria
Syfovre
Pegcetacoplan
2023-02-17
2026-2038
Paroxysmal hemoglobinuria
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pegcetacoplan
vascular diseases
,
thrombotic microangiopathies
,
hemolytic anemia autoimmune
,
paroxysmal hemoglobinuria
,
hemoglobinuria
Sodium chloride
healthy volunteers/patients
,
parkinson disease
,
progressive supranuclear palsy
,
paralysis
,
psoriatic arthritis
,
pharmacokinetics
,
connective tissue diseases
,
immune system diseases
,
autoimmune diseases
,
skin and connective tissue diseases
,
systemic lupus erythematosus
,
carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
psoriasis
,
crohn disease
,
spondylarthritis
,
spondylitis
,
axial spondyloarthritis
,
epilepsy
,
non-radiographic axial spondyloarthritis
,
ankylosing spondylitis
,
intermittent claudication
,
interstitial cystitis
,
cystitis
,
arthritis
,
rheumatoid arthritis
,
arterial occlusive diseases
,
human influenza
,
peripheral arterial disease
Aspartame
tuberculosis
,
neoplasms
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
deficiency diseases
,
paraproteinemias
,
hiv infections
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
breast neoplasms
,
immune system diseases
,
hematologic neoplasms
,
type 2 diabetes mellitus
,
uveitis
,
metabolic diseases
,
disease
,
lipidoses
,
immunoglobulin g4-related disease
,
malaria
,
falciparum malaria
,
whooping cough
,
tetanus
,
diphtheria
,
tetany
,
polycystic kidney diseases
,
autosomal dominant polycystic kidney
,
arthrogryposis
,
renal insufficiency
,
hematologic diseases
,
blood protein disorders
,
neoplasms by histologic type
,
prostatic neoplasms
,
circulating neoplastic cells
,
heart transplantation
,
non-small-cell lung carcinoma
,
lung neoplasms
,
carcinoma
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
neoplasm metastasis
,
anemia
,
aplastic anemia
,
multiple myeloma
,
plasma cell neoplasms
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
meningococcal infections
,
hemolytic anemia autoimmune
,
meningitis
,
meningococcal meningitis
,
stomach neoplasms
,
hemophilia a
,
kidney diseases
,
gaucher disease
,
smoldering multiple myeloma
,
hemophilia b
,
chronic renal insufficiency
,
hyperphosphatemia
,
multiple sclerosis
,
sclerosis
,
homozygous familial hypercholesterolemia
,
pharyngitis
,
tonsillitis
,
healthy volunteers/patients
,
asthma
,
glycogen storage disease type ii
,
glycogen storage disease
,
atopic dermatitis
,
dermatitis
,
lymphoma
,
eczema
,
diabetes mellitus
,
hyperglycemia
,
glycogen storage disease type iii
,
non-hodgkin lymphoma
,
osteoporosis
,
postmenopausal osteoporosis
,
lymphoproliferative disorders
Nepidermin
breast neoplasms
,
carcinoma
,
neoplasms
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
non-small-cell lung carcinoma
,
neoplasm metastasis
,
myofascial pain syndromes
,
fibromyalgia
,
syndrome
,
hemangioma
,
port-wine stain
,
capillary hemangioma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
melanoma
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use